Steve Elms, Director at ADMA Biologics, holds 2.14M shares in ADMA Biologics (Ticker: ADMA), holds 328.34K shares in Marker Therapeutics (Ticker: MRKR), holds 2.74M shares in Zosano Pharma (Ticker: ZSANQ). Most recently, Steve Elms Bought ― shares of ADMA Biologics on Mar 09, 2026 for an estimated value of $217.42K.
Steve Elms latest transaction was an Informative Buy of $217.42K.
What was Steve Elms's most profitable transaction?
Steve Elms’s most profitable transaction was an Informative Buy of LOXO stock on August 6, 2014. The return on the trade was 55.90%.
What is Steve Elms's role in ADMA Biologics?
Steve Elms's role in ADMA Biologics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.